Kim, Norman N.,McVicar, William K.,McCauley, Thomas,Baumgartner, Rudolf A.
申请号：
AU2011203897
公开号：
AU2011203897B2
申请日:
2011.01.11
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A1 agonist and to a method of reducing intraocular pressure (IOP) in a subject using such combination or kit. The invention is particularly directed to a combination of latanoprost marketed under the brand Xalatan
